FDA approves polypill Widaplik for hypertension
The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.
Jun 12, 2025
0
26
Organic Chemicals: News and Research on Indapamide
MeSH tree: D02.065.884.540
Two-medication combo pill lowered blood pressure among adults in India
Medication variations that combined two of three different blood pressure-lowering medications into a single pill worked equally well in reducing blood pressure and were safe among adults in India, according to late-breaking ...
Nov 18, 2024
0
14
Novel low-dose triple single-pill combination shows efficacy and tolerability in two international trials
A low-dose triple single-pill combination was effective at lowering blood pressure (BP) in two trials presented in a Hot Line session today at ESC Congress 2024.
Sep 3, 2024
0
32
Single tablet with four BP-lowering drugs found more effective than taking three drugs in separate pills
A single-pill combination of four BP-lowering medications was significantly more effective than a combination of three medications, according to late-breaking research presented in a Hot Line session August 31 at ESC Congress ...
Sep 2, 2024
0
42
Novel low-dose 3-in-1 blood pressure pill significantly outperforms standard care, study shows
New research shows that a treatment plan based on a novel combination of low doses of three anti-hypertensive drugs in a single pill—known as GMRx2—was superior to a high-quality standard care treatment plan at lowering blood ...
Aug 31, 2024
0
339
Study shows one injection of novel drug cuts systolic blood pressure by up to 12 mmHg
A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to 12 mmHg on average at ...
Apr 8, 2024
0
85
